Youth Metacognitive Therapy Feasibility Trial
Key facts
- Who runs it
- University of Manchester
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 95 people enrolled
- Started
- 23 May 2022
- Ended
- 4 Apr 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Treatment as usual: Control
- Group Metacognitive Therapy (Group-MCT): Experimental
- Record updated
- 3 June 2024
Who can take part
- Age
- 11 years to 16 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Seeking treatment for emotional disorder symptoms (i.e. generalized anxiety disorder, panic disorder, agoraphobia, post-traumatic stress disorder, obsessive compulsive disorder, social anxiety and/or depression)
- Native fluency in English language
- Medication permitted but must be stabilised for 6 weeks
Who cannot take part
- Head injury/organic impairment
- Formal diagnosis or under assessment for Autism Spectrum Disorder or Attention Deficit-Hyperactivity Disorder
- Eating Disorder
- Presence of significant risk or safeguarding concerns
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
One in eight children and young people (CYP) suffer mental health problems needing support or treatment and 5% have more than one such problem. The effects can be major, affecting CYP emotionally and functionally, impacting progress at school, relationships with others and increasing long term risk of mental health problems. Parents, schools, policy makers and the NHS often struggle to find the best way to help, especially within their limited budgets. The UK Government and the NHS have highlighted the need to improve mental health in CYP.
Read full original descriptionShow less
The most common treatment is cognitive behavioural therapy; however this can be time consuming, needs to be delivered over many weeks, must focus on the most upsetting problem first and is not very effective. One way to overcome this is to evaluate a group therapy that can treat multiple mental health problems at once. This new treatment is called Metacognitive Therapy (MCT).
The aim of the study is to see if participating in a randomized trial of Group MCT is a feasible and acceptable treatment for CYP suffering with anxiety, stress, depression, or a combination in comparison to usual care. This allows us to test key questions about recruitment and drop-out rates, test the protocol, and gain information about MCT including training and supervision needs of clinicians and the experience of patients receiving it.
The 2 groups in the trial
- Usual Treatment (Control)Existing treatment, for comparison
Participants allocated to the control group will receive treatment as usual under the child and adolescent mental health service.
Treatment: Treatment as usual: Control
- Group MCT (Intervention)Treatment being tested
Participants allocated to the intervention group will receive group metacognitive therapy sessions.
Treatment: Group Metacognitive Therapy (Group-MCT): Experimental
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Youth Metacognitive Therapy (YoMETA): A Single-Blind Parallel Randomised Feasibility Trial
- Record updated
- 3 June 2024